title: Clinically occult cutaneous metastases.
abstract: Cutaneous metastases present themselves in a variety of clinical patterns and tend to be manifested as indurated papules/nodules/tumors. Some of those clinical expressions are unique for certain types of metastases. This report describes an entirely different phenomenon of clinically incognito cutaneous metastases that were only apparent histopathologically as an incidental finding.
authors.affiliation: Institute for Dermatopathology, Conshohocken, Pennsylvania 19428, USA. kresnik@ameripath.com
authors.forename: Kenneth S
authors.initials: KS
authors.lastname: Resnik
authors.forename: Mario
authors.initials: M
authors.lastname: DiLeonardo
authors.forename: George
authors.initials: G
authors.lastname: Gibbons
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000077384:Anastrozole; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy / Q000009:adverse effects; D001943:Breast Neoplasms / Q000473:pathology* / Q000601:surgery; D000069287:Capecitabine; D002277:Carcinoma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*; D002280:Basal Cell Carcinoma / Q000473:pathology / Q000601:surgery; D018275:Carcinoma, Lobular / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000556:secondary* / Q000601:surgery; D018279:Carcinoma, Signet Ring Cell / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives; D005153:Facial Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary* / Q000601:surgery; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D000077267:Fulvestrant; D006801:Humans; D033162:Incidental Findings; D000077289:Letrozole; D015409:Mastectomy, Radical; D019290:Megestrol Acetate / Q000008:administration & dosage; D008545:Melanoma / Q000473:pathology / Q000601:surgery; D016609:Neoplasms, Second Primary / Q000473:pathology / Q000601:surgery; D009360:Neoplastic Cells, Circulating; D009570:Nitriles / Q000008:administration & dosage / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000556:secondary* / Q000601:surgery; D013629:Tamoxifen / Q000008:administration & dosage / Q000627:therapeutic use; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use; D014945:Wound Healing
chemical_list: D000964:Antimetabolites, Antineoplastic; D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D020845:Selective Estrogen Receptor Modulators; D014230:Triazoles; D013629:Tamoxifen; D003841:Deoxycytidine; D000077267:Fulvestrant; D000077384:Anastrozole; D004958:Estradiol; D000069287:Capecitabine; D000077289:Letrozole; D019290:Megestrol Acetate; D005472:Fluorouracil